Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NORDLYSKLINIKKEN AS
AS
Active
Org 830662782
Garnveien 45, 8013 Bodø
Traditional, complementary and alternative medicine activities · NACE 8696
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 378K
+27% vs 2023
EBITDA margin
11.7%
+478% vs 2023
Equity ratio
31.1%
Financial strength
Net profit 2024
NOK 23K
+246% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 378K
+27%
EBITDA
NOK 44K
+478%
Net profit
NOK 23K
+246%
Total assets
NOK 120K
-14%
Equity
NOK 37K
+163%
Employees
0
—
Company information
Legal name
NORDLYSKLINIKKEN AS
Org number
830662782
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
17. januar 2023
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Helse, velvære, hud og kroppsterapi, veiledning, undervisning, fotpleie. Hudpleie, acnebehandling, dyprens, spesialbbehandlinger og massasje.
Contact
Address
Garnveien 45, 8013 Bodø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Traditional, complementary and alternative medicine activities
Companies in Bodø
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
0
299
378
Staff expenses
−0
−2
−86
EBITDA
0
8
44
Depreciation & amort.
−0
−23
−19
EBIT
0
−16
25
Net financials
0
0
0
Profit before tax
0
−16
25
Tax
−0
−0
2
Net profit
0
−16
23
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
30
139
120
Equity
30
14
37
Long-term debt
0
53
0
Short-term debt
0
71
82
Total debt
0
124
82
Financial ratios
5-year trend
EBITDA margin
11.7%
This company
15.8%
Market median
-26% vs market
2022
2024
Equity ratio
31.1%
This company
38.2%
Market median
+19% vs market
2022
2024
Return on equity
62.0%
This company
18.4%
Market median
+237% vs market
2022
2024
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
2022
2024
Asset turnover
3.16×
This company
1.12×
Market median
+182% vs market
2022
2024
Debt / equity
2.21×
This company
0.62×
Market median
-256% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-12-16 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MJ
Marit Janne Ra
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of NORDLYSKLINIKKEN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Marit Janne Ra
Chief Executive Officer
0 companies